Today, a Chinese company announced plans to deploy AI-powered testing in IVF clinics, promising to boost profits and speed up the process. The move, reported by the South China Morning Post, marks another step in the corporate takeover of reproductive healthcare—where technology isn’t about care, but about efficiency, control, and extracting maximum value from those desperate to start a family. **IVF Was Never About Healthcare—It’s a Market** In vitro fertilization (IVF) was sold as a medical breakthrough, a way to help people overcome infertility. But from the beginning, it’s been a lucrative industry, with clinics charging exorbitant fees for procedures that often fail. Now, with AI entering the picture, the focus isn’t on improving success rates or making care more accessible—it’s on squeezing more profit from a system already rigged against patients. The company behind this AI push isn’t a healthcare provider; it’s a tech firm looking to capitalize on a growing market. By automating parts of the IVF process, they’re not just speeding up treatments—they’re turning human reproduction into a data-driven, profit-optimized assembly line. The implications are chilling: fewer doctors making critical decisions, more reliance on opaque algorithms, and a system where the cost of failure is borne by patients, not corporations. **AI in Healthcare: A Tool for Control, Not Care** This isn’t the first time AI has been hailed as a revolution in healthcare, and it won’t be the last. But let’s be clear: AI in medicine isn’t about healing—it’s about control. Whether it’s predictive algorithms deciding who gets treatment or automated systems streamlining care for maximum efficiency, the goal is the same: to turn healthcare into a commodity, where access is determined by profit margins, not need. In the case of IVF, AI-powered testing could mean faster diagnoses, but it could also mean more standardized, impersonal care. Clinics might prioritize patients based on profitability rather than medical urgency, and those who can’t afford the latest tech could be left behind entirely. Worse, the data collected from these AI systems could be used to further segment and exploit patients, turning their most intimate struggles into a goldmine for tech companies and investors. **Who Really Benefits?** The company behind this AI push stands to make a fortune, but what about the patients? IVF is already prohibitively expensive for many, with success rates that vary wildly depending on age, health, and access to care. Adding AI into the mix won’t change the fact that the system is designed to profit from desperation. If anything, it will make it worse—by further distancing patients from the human professionals who should be guiding their care. And let’s not forget the broader implications. AI in reproductive healthcare isn’t just about IVF—it’s part of a larger trend of tech companies inserting themselves into every aspect of human life. From fertility tracking apps to AI-driven prenatal care, the goal is to turn reproduction into a data-driven, corporate-controlled process. The message is clear: your body, your choices, your future—they’re all just another market to be exploited. **Why This Matters:** This isn’t just about IVF—it’s about the corporate takeover of human reproduction. AI-powered testing in fertility clinics is the latest example of how technology is being used to turn healthcare into a profit-driven industry, where the needs of patients are secondary to the bottom line. The introduction of AI into IVF doesn’t just risk making care more impersonal; it risks deepening inequalities, prioritizing those who can pay, and turning one of the most intimate aspects of human life into a data-driven transaction. For those of us who believe healthcare should be about care, not profit, this is a warning. The same forces that have turned hospitals into businesses, drugs into luxury items, and insurance into a labyrinth of bureaucracy are now coming for reproductive health. AI in IVF isn’t a step forward—it’s a step toward a future where every aspect of human life is commodified, controlled, and sold to the highest bidder. But it doesn’t have to be this way. Communities around the world are already building alternatives—mutual aid networks, grassroots clinics, and open-source tools that put people before profit. The question is whether we’ll let corporations dictate the future of reproduction, or whether we’ll fight for a system that serves the many, not the few.
